WHO designated JN.1, a subset of BA.2.86 Omicron, as a separate variant due to its rapid rise in recent weeks.
COVID-19 Epidemiological Update
Go to source) In the latest epidemiological update, the UN health body reported over 850,000 new cases worldwide in the 28-day period from November 20 to December 17. The number of new deaths decreased by 8 percent as compared to the previous 28-day period, with over 3,000 new fatalities reported. As of December 17, over 772 million confirmed cases and nearly seven million deaths have been reported globally.
COVID-19 Hospitalizations and ICU Admissions Surge
During the period from November 13 to December 10, over 118,000 new Covid hospitalizations and over 1,600 new intensive care unit (ICU) admissions have been recorded with an overall increase of 23 percent and 51 percent respectively amongst the countries reporting consistently within the current and past reporting periods. However, EG.5 remains to be the most reported VOI globally.
COVID in Children
Covid-19 virus has affected many children during the second wave. Many factors play a role in COVID in children and the management of COVID in children. Therefore, it is highly essential for parents to know and understand the symptoms in children.
Covid-19 virus has affected many children during the second wave. Many factors play a role in COVID in children and the management of COVID in children. Therefore, it is highly essential for parents to know and understand the symptoms in children.
‘Globally, there was a 317 percent surge in the count of new deaths within a 28-day period compared to the previous one, tallying 50 fresh fatalities. #COVID #coronavirus ’
At the global level, during the past 28 days, a total of 118,958 new hospitalizations and 1,610 new intensive care unit (ICU) admissions were reported from 58 and 36 countries, respectively. The South-East Asia Region reported over 9,200 new cases, a 388 percent increase as compared to the previous 28-day period. The highest numbers of new cases were reported from Indonesia (3,725), followed by India (3,241) and Thailand (2,120). The highest numbers of new deaths were reported from India (21 new deaths), Thailand (16 new deaths) and Indonesia (12 new deaths).The WHO emphasized that current vaccines continue to provide protection against severe disease and death from the JN.1 variant and other circulating variants of SARS-CoV-2.
The organisation is closely monitoring the evidence and will update the risk evaluation of JN.1 as needed.To mitigate the spread of these respiratory illnesses, the WHO advised individuals to adopt preventive measures, including wearing masks in crowded or poorly ventilated areas, maintaining a safe distance, practicing respiratory etiquette, regular hand hygiene, and getting tested for Covid or influenza if symptoms arise or after exposure.
JN.1 Impact on India's COVID Cases, Unlikely to spur a Big Wave
JN.1 isn't your typical variant; it's a distinct sub-variant within the Omicron strain, precisely denoted as BA.2.86.
JN.1 isn't your typical variant; it's a distinct sub-variant within the Omicron strain, precisely denoted as BA.2.86.
- COVID-19 Epidemiological Update - (https://www.who.int/docs/default-source/coronaviruse/situation-reports/20231222_covid-19_epi_update-handover_162.pdf?sfvrsn=9041e915_4&download=true)
New COVID JN. 1 Variant Raises Global Health Concern
WHO has called for increased surveillance of infectious diseases to combat the worldwide surge of new COVID JN.1 variant.
WHO has called for increased surveillance of infectious diseases to combat the worldwide surge of new COVID JN.1 variant.
CDC Identifies Novel COVID-19 Strains JN.1 and HV.1
The CDC flags concerns over novel COVID-19 strains, JN.1 and HV.1, noting their potential to evade the immune system.
The CDC flags concerns over novel COVID-19 strains, JN.1 and HV.1, noting their potential to evade the immune system.
